Concentrated insulins: the new basal insulins
Elizabeth M Lamos,1 Lisa M Younk,2 Stephen N Davis3 1Division of Endocrinology, Diabetes and Nutrition, 2Department of Medicine, University of Maryland School of Medicine, 3Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA Introduction: Insulin therapy plays a critica...
Saved in:
Main Authors: | Lamos EM (Author), Younk LM (Author), Davis SN (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol
by: Sondra Davis, et al.
Published: (2017) -
Lixisenatide as add-on therapy to basal insulin
by: Brown DX, et al.
Published: (2013) -
Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
by: Shafie AA, et al.
Published: (2020) -
Detemir as a once-daily basal insulin in type 2 diabetes
by: Nelson SE
Published: (2011) -
Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
by: Andrew Ahmann
Published: (2015)